LANTERN PHARMA
Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action. Lantern also rescues and revitalizes abandoned or failed cancer drugs using machine learning techniques, genomic data and precision oncology trials. Lantern Pharma recognizes that the high cost and low success rates in oncology drug development largely stem from the inability to appropriately stratify patient populations prior to enrollment, and also ... from the inability to fully elucidate mechanisms of action that can suggest potent therapy combinations. Our approach, which leverages our RADR™ platform helps to provide rapid, meaningful insight to both of these central problems in oncology. Lantern is focused on accelerating personalized cancer therapy development through the use of AI and genomic-based patient stratification.
LANTERN PHARMA
Industry:
Artificial Intelligence Biopharma Biotechnology Pharmaceutical Therapeutics
Founded:
2013-01-01
Address:
Dallas, Texas, United States
Country:
United States
Website Url:
http://www.lanternpharma.com
Total Employee:
11+
Status:
Active
Contact:
972-277-1136
Email Addresses:
[email protected]
Total Funding:
94.98 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Euro IPv6 JsDelivr Cloudflare JS
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Checkmate Pharmaceuticals
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
LabGenius
LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Employees Featured
Founder
Stock Details
Investors List
GPG Ventures
GPG Ventures investment in Series A - Lantern Pharma
Bios Partners
Bios Partners investment in Series A - Lantern Pharma
Green Park & Golf Ventures
Green Park & Golf Ventures investment in Funding Round - Lantern Pharma
Health Wildcatters
Health Wildcatters investment in Pre Seed Round - Lantern Pharma
Official Site Inspections
http://www.lanternpharma.com Semrush global rank: 3.46 M Semrush visits lastest month: 4.39 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Lantern Pharma"
About Us - Lantern Pharma Inc.
Lantern Pharma is a clinical stage oncology company that leverages Artificial Intelligence, Machine Learning, and genomics to develop targeted cancer therapies.See details»
Lantern Pharma Inc - Precision Oncology Medicine
Dec 11, 2024 Lantern Pharma is an oncology-focused, emerging, clinical stage pharma leveraging Artificial Intelligence, Genomics, and Machine Learning to transform the cost, pace, and timeline of drug discovery and development.See details»
Company Information :: Lantern Pharma Inc. (LTRN)
Lantern Pharma is a clinical stage biotechnology company focused on innovating the cancer drug development process by using advanced genomics, machine learning, and artificial intelligence ("A.I."). Our A.I. platform, known as RADR …See details»
Our Team - Lantern Pharma Inc.
We take pride in our pioneering, world class team dedicated to the advancement of drug development and patient care.See details»
Lantern Pharma Inc. (Nasdaq: LTRN) - LinkedIn
Lantern Pharma Inc. (Nasdaq: LTRN) | 4,970 followers on LinkedIn. Leveraging Artificial Intelligence to Rescue and Develop Cancer Therapies | Lantern Pharma, Inc. is a clinical stage ...See details»
Board of Directors :: Lantern Pharma Inc. (LTRN)
Passionate about the use of A.I. and machine learning to change the risk, cost, and timelines in the highly interdisciplinary field of personalized medicine. Panna Sharma is the President, CEO, and Board Member of Lantern Pharma Inc., a …See details»
Lantern Pharma - Crunchbase Company Profile
Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomicsSee details»
Lantern Pharma Inc Company Profile - Overview - GlobalData
Gain a 360-degree view of Lantern Pharma Inc and make more informed decisions for your business Gain a 360-degree view of Lantern Pharma Inc and make more informed decisions …See details»
Lantern Pharma 2025 Company Profile: Stock Performance
Information on stock, financials, earnings, subsidiaries, investors, and executives for Lantern Pharma. Use the PitchBook Platform to explore the full profile.See details»
Lantern Pharma - 2025 Company Profile - Tracxn
2 days ago Lantern Pharma - Developing drug and companion diagnostics for multi-drug resistant cancers. Public Company. Raised a total funding of $7.12M over 5 rounds from 4 …See details»
Lantern Pharma: Revenue, Worth, Valuation & Competitors 2025
Lantern Pharma has an estimated revenue of $1.5M, and 31 employees. Alternatives of Lantern Pharma are Spire Digital, 10Web.io and Loyal.See details»
Lantern Pharma Provides Business Updates and Fourth Quarter
Mar 27, 2025 You may access our Annual Report on Form 10-K for the year ended December 31, 2024 under the investor SEC filings tab of our website at www.lanternpharma.com or on …See details»
Lantern Pharma Inc. (LTRN)
Lantern Pharma is a clinical stage biotechnology company focused on innovating the cancer drug development process by using advanced genomics, machine learning, and artificial …See details»
Culture - Lantern Pharma Inc.
Lantern Pharma is dedicated to fostering a workplace environment that keeps our employees inspired and provides them with the vision, resources and support they need to succeed.See details»
Lantern Pharma Reports First Quarter 2025 Financial Results and ...
1 day ago Lantern’s Phase 2 HARMONIC™ trial for LP-300 continued to advance during Q1 2025 with patients enrolled in Japan and Taiwan and ongoing enrollment in the US. Never …See details»
Financial Results :: Lantern Pharma Inc. (LTRN)
Fiscal Year Ended Dec 31, 2024Earnings ReleaseSee details»
Contact Us - Lantern Pharma Inc.
Get in touch with Lantern Pharma - We are constantly looking for opportunities to collaborate with like-minded companies, organizations, and people.See details»
Lantern Pharma Reports First Quarter 2025 Financial Results and ...
1 day ago DALLAS, May 15, 2025 -- (BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging its proprietary RADR ® artificial …See details»
Lantern Pharma Reports First Quarter 2025 Financial Results and ...
1 day ago Completion of LP-184 Phase 1a clinical trial enrollment with 62-65 patients across a range of solid tumors expected by end of June 2025. Maintained disciplined capital …See details»
Lantern Pharma Reports First Quarter 2025 Financial Results and ...
1 day ago Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging its proprietary RADR ® artificial intelligence (AI) and machine learning (ML) …See details»